H.R. 6674

Thu, 12/07/2023 - 12:00

Update Type

Bills Introduced

would provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS).

https://www.congress.gov/bill/118th-congress/house-bill/6674

Committee Name

Committee on Energy and Commerce

Sponsor Name

Kildee

Sponsor Party Affiliation

D-Mich.

Issue

2

Volume

54

Update Issue

36

Update Volume

53

Congressional Record Number

169 Cong. Rec. H6740

Congress Number

118

You must be an ELI Member to access the full content.

You are not logged in. To access this content:

• Log in,
• Become a member